The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 30 Jul 2003
doi: 10.1242/jcs.00691
Research Article
KSHV vFLIP binds to IKK-
to activate IKK
Nigel Field,
Walter Low,
Mark Daniels,
Steven Howell,
Laurent Daviet,
Chris Boshoff,
and
Mary Collins*
* Author for correspondence (e-mail: mary.collins{at}ucl.ac.uk)
When expressed in heterologous cells, the viral FLIP protein (vFLIP) of Kaposi's-sarcoma-associated herpesvirus (KSHV) has been reported both to block Fas-mediated apoptosis and to activate the NF-
B activation pathway by interaction with I
B kinase (IKK). In a yeast-two-hybrid screen, we identified IKK
as an interacting partner of vFLIP. We expressed fragments of IKK
in mammalian cells and bacteria, and identified the central CCR3/4 (amino acids 150-272) as the vFLIP binding region. To investigate the proteins interacting with vFLIP in a KSHV-infected primary effusion lymphoma (PEL) cell line, we immunoprecipitated vFLIP and identified four associated proteins by mass spectrometry: IKK components IKK
,
and
, and the chaperone, Hsp90. Using gel filtration chromatography, we demonstrated that a single population of vFLIP in the cytoplasm of PEL cells co-eluted and co-precipitated with an activated IKK complex. An inhibitor of Hsp90, geldanamycin, inhibited IKK's kinase activity induced by vFLIP and killed PEL cells, suggesting that vFLIP activation of IKK contributes to PEL cell survival.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. B. Nichols and J. L. Shisler
Poxvirus MC160 Protein Utilizes Multiple Mechanisms To Inhibit NF-{kappa}B Activation Mediated via Components of the Tumor Necrosis Factor Receptor 1 Signal Transduction Pathway
J. Virol.,
April 1, 2009;
83(7):
3162 - 3174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Rowe, L. Lopes, N. Brown, S. Efklidou, T. Smallie, S. Karrar, P. M. Kaye, and M. K. Collins
Expression of vFLIP in a Lentiviral Vaccine Vector Activates NF-{kappa}B, Matures Dendritic Cells, and Increases CD8+ T-Cell Responses
J. Virol.,
February 15, 2009;
83(4):
1555 - 1562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Carbone, E. Cesarman, M. Spina, A. Gloghini, and T. F. Schulz
HIV-associated lymphomas and gamma-herpesviruses
Blood,
February 5, 2009;
113(6):
1213 - 1224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Thurau, G. Marquardt, N. Gonin-Laurent, K. Weinlander, E. Naschberger, R. Jochmann, K. R. Alkharsah, T. F. Schulz, M. Thome, F. Neipel, et al.
Viral Inhibitor of Apoptosis vFLIP/K13 Protects Endothelial Cells against Superoxide-Induced Cell Death
J. Virol.,
January 15, 2009;
83(2):
598 - 611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mohan, R. Konopinski, B. Yan, V. E. Centonze, and M. Natarajan
High glucose-induced IKK-Hsp-90 interaction contributes to endothelial dysfunction
Am J Physiol Cell Physiol,
January 1, 2009;
296(1):
C182 - C192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Sethi, B. Sung, and B. B. Aggarwal
Nuclear Factor-{kappa}B Activation: From Bench to Bedside
Experimental Biology and Medicine,
January 1, 2008;
233(1):
21 - 31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hinz, M. Broemer, S. C. Arslan, A. Otto, E.-C. Mueller, R. Dettmer, and C. Scheidereit
Signal Responsiveness of I{kappa}B Kinases Is Determined by Cdc37-assisted Transient Interaction with Hsp90
J. Biol. Chem.,
November 2, 2007;
282(44):
32311 - 32319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Panner, J. C. Murray, M. S. Berger, and R. O. Pieper
Heat Shock Protein 90{alpha} Recruits FLIPS to the Death-Inducing Signaling Complex and Contributes to TRAIL Resistance in Human Glioma
Cancer Res.,
October 1, 2007;
67(19):
9482 - 9489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Matta, L. Mazzacurati, S. Schamus, T. Yang, Q. Sun, and P. M. Chaudhary
Kaposi's Sarcoma-associated Herpesvirus (KSHV) Oncoprotein K13 Bypasses TRAFs and Directly Interacts with the I{kappa}B Kinase Complex to Selectively Activate NF-{kappa}B without JNK Activation
J. Biol. Chem.,
August 24, 2007;
282(34):
24858 - 24865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Rae, S. Langa, S. J. Tucker, and D. J. MacEwan
Elevated NF-{kappa}B responses and FLIP levels in leukemic but not normal lymphocytes: reduction by salicylate allows TNF-induced apoptosis
PNAS,
July 31, 2007;
104(31):
12790 - 12795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Caselli, S. Fiorentini, C. Amici, D. Di Luca, A. Caruso, and M. G. Santoro
Human herpesvirus 8 acute infection of endothelial cells induces monocyte chemoattractant protein 1-dependent capillary-like structure formation: role of the IKK/NF-{kappa}B pathway
Blood,
April 1, 2007;
109(7):
2718 - 2726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Xu and D. Ganem
Induction of chemokine production by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells
J. Gen. Virol.,
January 1, 2007;
88(1):
46 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Grossmann, S. Podgrabinska, M. Skobe, and D. Ganem
Activation of NF-{kappa}B by the Latent vFLIP Gene of Kaposi's Sarcoma-Associated Herpesvirus Is Required for the Spindle Shape of Virus-Infected Endothelial Cells and Contributes to Their Proinflammatory Phenotype
J. Virol.,
July 15, 2006;
80(14):
7179 - 7185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. O. Jones and A. M. Arvin
Inhibition of the NF-{kappa}B Pathway by Varicella-Zoster Virus In Vitro and in Human Epidermal Cells In Vivo.
J. Virol.,
June 1, 2006;
80(11):
5113 - 5124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Keller, D. Hernandez-Hopkins, J. Vider, V. Ponomarev, E. Hyjek, E. J. Schattner, and E. Cesarman
NF-{kappa}B is essential for the progression of KSHV- and EBV-infected lymphomas in vivo
Blood,
April 15, 2006;
107(8):
3295 - 3302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Madureira, P. Matos, I. Soeiro, L. K. Dixon, J. P. Simas, and E. W.-F. Lam
Murine {gamma}-Herpesvirus 68 Latency Protein M2 Binds to Vav Signaling Proteins and Inhibits B-cell Receptor-induced Cell Cycle Arrest and Apoptosis in WEHI-231 B Cells
J. Biol. Chem.,
November 11, 2005;
280(45):
37310 - 37318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nakagiri, A. Murakami, S. Takada, T. Akiyama, and S. Yonehara
Viral FLIP Enhances Wnt Signaling Downstream of Stabilized {beta}-Catenin, Leading to Control of Cell Growth
Mol. Cell. Biol.,
November 1, 2005;
25(21):
9249 - 9258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Chugh, H. Matta, S. Schamus, S. Zachariah, A. Kumar, J. A. Richardson, A. L. Smith, and P. M. Chaudhary
Constitutive NF-{kappa}B activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice
PNAS,
September 6, 2005;
102(36):
12885 - 12890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Klass, L. T. Krug, V. P. Pozharskaya, and M. K. Offermann
The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production
Blood,
May 15, 2005;
105(10):
4028 - 4034.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Bechtel, R. C. Winant, and D. Ganem
Host and Viral Proteins in the Virion of Kaposi's Sarcoma-Associated Herpesvirus
J. Virol.,
April 15, 2005;
79(8):
4952 - 4964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Bracken, M. L. Whitelaw, and D. J. Peet
Activity of Hypoxia-inducible Factor 2{alpha} Is Regulated by Association with the NF-{kappa}B Essential Modulator
J. Biol. Chem.,
April 8, 2005;
280(14):
14240 - 14251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. T. Lam, R. E. Davis, J. Pierce, M. Hepperle, Y. Xu, M. Hottelet, Y. Nong, D. Wen, J. Adams, L. Dang, et al.
Small Molecule Inhibitors of I{kappa}B Kinase Are Selectively Toxic for Subgroups of Diffuse Large B-Cell Lymphoma Defined by Gene Expression Profiling
Clin. Cancer Res.,
January 1, 2005;
11(1):
28 - 40.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-F. Pittet, H. Lee, M. Pespeni, A. O'Mahony, J. Roux, and W. J. Welch
Stress-Induced Inhibition of the NF-{kappa}B Signaling Pathway Results from the Insolubilization of the I{kappa}B Kinase Complex following Its Dissociation from Heat Shock Protein 90
J. Immunol.,
January 1, 2005;
174(1):
384 - 394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. DiPerna, J. Stack, A. G. Bowie, A. Boyd, G. Kotwal, Z. Zhang, S. Arvikar, E. Latz, K. A. Fitzgerald, and W. L. Marshall
Poxvirus Protein N1L Targets the I-{kappa}B Kinase Complex, Inhibits Signaling to NF-{kappa}B by the Tumor Necrosis Factor Superfamily of Receptors, and Inhibits NF-{kappa}B and IRF3 Signaling by Toll-like Receptors
J. Biol. Chem.,
August 27, 2004;
279(35):
36570 - 36578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kreuz, D. Siegmund, J.-J. Rumpf, D. Samel, M. Leverkus, O. Janssen, G. Hacker, O. Dittrich-Breiholz, M. Kracht, P. Scheurich, et al.
NF{kappa}B activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP
J. Cell Biol.,
August 2, 2004;
166(3):
369 - 380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Matta and P. M. Chaudhary
Activation of alternative NF-{kappa}B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1{beta}-converting enzyme inhibitory protein (vFLIP)
PNAS,
June 22, 2004;
101(25):
9399 - 9404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Guasparri, S. A. Keller, and E. Cesarman
KSHV vFLIP Is Essential for the Survival of Infected Lymphoma Cells
J. Exp. Med.,
April 5, 2004;
199(7):
993 - 1003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Matta, Q. Sun, G. Moses, and P. M. Chaudhary
Molecular Genetic Analysis of Human Herpes Virus 8-encoded Viral FLICE Inhibitory Protein-induced NF-{kappa}B Activation
J. Biol. Chem.,
December 26, 2003;
278(52):
52406 - 52411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Sun, S. Zachariah, and P. M. Chaudhary
The Human Herpes Virus 8-Encoded Viral FLICE-inhibitory Protein Induces Cellular Transformation via NF-{kappa}B Activation
J. Biol. Chem.,
December 26, 2003;
278(52):
52437 - 52445.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2003